Fatty Acid Synthase Modulates Homeostatic Responses to Myocardial Stress*

Fatty acid synthase (FAS) promotes energy storage through de novo lipogenesis and participates in signaling by the nuclear receptor PPARα in noncardiac tissues. To determine if de novo lipogenesis is relevant to cardiac physiology, we generated and characterized FAS knockout in the myocardium (FASKard) mice. FASKard mice develop normally, manifest normal resting heart function, and have normal cardiac PPARα signaling as well as fatty acid oxidation. However, they decompensate with stress. Most die within 1 h of transverse aortic constriction, probably due to arrhythmia. Voltage clamp measurements of FASKard cardiomyocytes show hyperactivation of L-type calcium channel current that could not be reversed with palmitate supplementation. Of the classic regulators of this current, Ca2+/calmodulin-dependent protein kinase II (CaMKII) but not protein kinase A signaling is activated in FASKard hearts, and knockdown of FAS in cultured cells activates CaMKII. In addition to being intolerant of the stress of acute pressure, FASKard hearts were also intolerant of the stress of aging, reflected as persistent CaMKII hyperactivation, progression to dilatation, and premature death by ∼1 year of age. CaMKII signaling appears to be pathogenic in FASKard hearts because inhibition of its signaling in vivo rescues mice from early mortality after transverse aortic constriction. FAS was also increased in two mechanistically distinct mouse models of heart failure and in the hearts of humans with end stage cardiomyopathy. These data implicate a novel relationship between FAS and calcium signaling in the heart and suggest that FAS induction in stressed myocardium represents a compensatory response to protect cardiomyocytes from pathological calcium flux.

[1]  J. Schneider,et al.  Macrophage Fatty-acid Synthase Deficiency Decreases Diet-induced Atherosclerosis* , 2010, The Journal of Biological Chemistry.

[2]  J. Nerbonne,et al.  Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents. , 2010, Journal of molecular and cellular cardiology.

[3]  F. Gao,et al.  The Cytoprotective Effects of Tumor Necrosis Factor Are Conveyed Through Tumor Necrosis Factor Receptor–Associated Factor 2 in the Heart , 2010, Circulation. Heart failure.

[4]  E. Abel,et al.  Rodent models of diabetic cardiomyopathy , 2009, Disease Models & Mechanisms.

[5]  John Turk,et al.  Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver , 2009, Cell.

[6]  U. Schotten,et al.  Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. , 2009, The Journal of clinical investigation.

[7]  M. Anderson CaMKII and a failing strategy for growth in heart. , 2009, The Journal of clinical investigation.

[8]  Tong Zhang,et al.  Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. , 2009, The Journal of clinical investigation.

[9]  M. Kendrick,et al.  Lysophosphatidyl choline modulates mechanosensitive L-type Ca2+ current in circular smooth muscle cells from human jejunum. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[10]  Hugo A. Katus,et al.  The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload , 2009, Proceedings of the National Academy of Sciences.

[11]  C. Nichols,et al.  Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus. , 2009, Cell metabolism.

[12]  H. Shimano SREBPs: physiology and pathophysiology of the SREBP family , 2009, The FEBS journal.

[13]  F. Saleem,et al.  Palmitoylation gates phosphorylation-dependent regulation of BK potassium channels , 2008, Proceedings of the National Academy of Sciences.

[14]  M. Loda,et al.  Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer , 2008, Laboratory Investigation.

[15]  Linda M. Boland,et al.  Polyunsaturated Fatty Acid Modulation of Voltage-Gated Ion Channels , 2008, Cell Biochemistry and Biophysics.

[16]  L. Glimcher,et al.  Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1 , 2008, Science.

[17]  L. Satin,et al.  Differential modulation of L-type calcium channel subunits by oleate. , 2008, American journal of physiology. Endocrinology and metabolism.

[18]  Yukio Horikawa,et al.  ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. , 2008, Endocrine journal.

[19]  T. Baukrowitz,et al.  How Highly Charged Anionic Lipids Bind and Regulate Ion Channels , 2008, The Journal of general physiology.

[20]  Y. Ikeda,et al.  Toward biologically targeted therapy of calcium cycling defects in heart failure. , 2008, Physiology.

[21]  M. Link,et al.  Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP. , 2008, The Journal of clinical investigation.

[22]  M. Lane,et al.  Brain fatty acid synthase activates PPARα to maintain energy homeostasis , 2007 .

[23]  Donald M Bers,et al.  Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. , 2007, Cardiovascular research.

[24]  Lan Cheng,et al.  Klf2 is an essential regulator of vascular hemodynamic forces in vivo. , 2006, Developmental cell.

[25]  A. Terzic,et al.  Protection conferred by myocardial ATP‐sensitive K+ channels in pressure overload‐induced congestive heart failure revealed in KCNJ11 Kir6.2‐null mutant , 2006, The Journal of physiology.

[26]  Jeffrey W. Smith,et al.  Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Mark E. Anderson,et al.  RETRACTED: L-Type Ca2+ Channel Facilitation Mediated by Phosphorylation of the β Subunit by CaMKII , 2006 .

[28]  S. Endo,et al.  Mechanisms for association of Ca2+/calmodulin-dependent protein kinase II with lipid rafts. , 2006, Biochemical and biophysical research communications.

[29]  M. Daly,et al.  Ca2+/Calmodulin-Dependent Protein Kinase II Is a Modulator of CARMA1-Mediated NF-κB Activation , 2006, Molecular and Cellular Biology.

[30]  Sheryl E. Koch,et al.  The L-type calcium channel in the heart: the beat goes on. , 2005, The Journal of clinical investigation.

[31]  T. Flagg,et al.  Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K(ATP). , 2005, Journal of molecular and cellular cardiology.

[32]  R. Liao Yin and Yang of Myocardial Transforming Growth Factor-&bgr;1: Timing Is Everything , 2005, Circulation.

[33]  J. Schneider,et al.  "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.

[34]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[35]  Guy Salama,et al.  Calmodulin kinase II inhibition protects against structural heart disease , 2005, Nature Medicine.

[36]  Masaki Inagaki,et al.  Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) Localization Acts in Concert with Substrate Targeting to Create Spatial Restriction for Phosphorylation* , 2005, Journal of Biological Chemistry.

[37]  M. Weis,et al.  Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium. , 2004, Cardiovascular research.

[38]  J. Nerbonne,et al.  Heterogeneous expression of repolarizing, voltage‐gated K+ currents in adult mouse ventricles , 2004, The Journal of physiology.

[39]  M. Anderson Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias? , 2004, Trends in cardiovascular medicine.

[40]  F. Charpentier,et al.  Remodeling of excitation-contraction coupling in transgenic mice expressing ATP-insensitive sarcolemmal KATP channels. , 2004, American journal of physiology. Heart and circulatory physiology.

[41]  R. Hammer,et al.  Hypertrophic Response to Angiotensin Ii Cardiac Function and an Unaltered Receptor Knockout Mice Have Normal Cardiomyocyte-specific Endothelin A , 2003 .

[42]  L. Miller,et al.  Alterations of gene expression in failing myocardium following left ventricular assist device support. , 2003, Physiological genomics.

[43]  Andrzej Witkowski,et al.  Structural and functional organization of the animal fatty acid synthase. , 2003, Progress in lipid research.

[44]  S. Chirala,et al.  Fatty acid synthesis is essential in embryonic development: Fatty acid synthase null mutants and most of the heterozygotes die in utero , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Tong Zhang,et al.  The &dgr;C Isoform of CaMKII Is Activated in Cardiac Hypertrophy and Induces Dilated Cardiomyopathy and Heart Failure , 2003, Circulation research.

[46]  A. Terzic,et al.  Kir6.2 is required for adaptation to stress , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Dan M Roden,et al.  Calmodulin Kinase II and Arrhythmias in a Mouse Model of Cardiac Hypertrophy , 2002, Circulation.

[48]  S. Woodman,et al.  Caveolae: From Cell Biology to Animal Physiology , 2002, Pharmacological Reviews.

[49]  D. Severson,et al.  A Role for Peroxisome Proliferator-activated Receptor α (PPARα) in the Control of Cardiac Malonyl-CoA Levels , 2002, The Journal of Biological Chemistry.

[50]  D. Bers Cardiac excitation–contraction coupling , 2002, Nature.

[51]  G. Christ,et al.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. , 2001, The Journal of biological chemistry.

[52]  W Grossman,et al.  LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice. , 2001, American journal of physiology. Heart and circulatory physiology.

[53]  M. Weckström,et al.  Cardiac mechanotransduction: from sensing to disease and treatment. , 2001, Trends in pharmacological sciences.

[54]  P. Herrero,et al.  A novel mouse model of lipotoxic cardiomyopathy. , 2001, The Journal of clinical investigation.

[55]  M. Bitzer,et al.  Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor* , 2001, The Journal of Biological Chemistry.

[56]  P. Jones,et al.  Tenascin-C in development and disease: gene regulation and cell function. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[57]  J. Ju,et al.  Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice , 2000, Nature Medicine.

[58]  K. Ueno Involvement of fatty acid synthase in axonal development in mouse embryos , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[59]  R. Passier,et al.  CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. , 2000, The Journal of clinical investigation.

[60]  K. Kim,et al.  Regulation of the fatty acid synthase promoter by insulin. , 2000, The Journal of nutrition.

[61]  G. J. van der Vusse,et al.  Cardiac fatty acid uptake and transport in health and disease. , 2000, Cardiovascular research.

[62]  P. Dunham,et al.  Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter. , 1999, American journal of physiology. Cell physiology.

[63]  D. Severson,et al.  Glucose and fatty acid metabolism in the isolated working mouse heart. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[64]  W. Wahli,et al.  Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting , 1999 .

[65]  Mark E. Anderson,et al.  CaM kinase augments cardiac L-type Ca2+ current: a cellular mechanism for long Q-T arrhythmias. , 1999, American journal of physiology. Heart and circulatory physiology.

[66]  M. Hellerstein De novo lipogenesis in humans: metabolic and regulatory aspects , 1999, European Journal of Clinical Nutrition.

[67]  G. Dorn,et al.  Decompensation of Pressure-Overload Hypertrophy in Gαq-Overexpressing Mice , 1998 .

[68]  P. Karczewski,et al.  Differentiation‐dependent expression of cardiac δ‐CaMKII isoforms , 1998 .

[69]  B. A. French,et al.  Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. , 1997, The Journal of clinical investigation.

[70]  C. Semenkovich,et al.  Regulation of fatty acid synthase (FAS). , 1997, Progress in lipid research.

[71]  H. C. Hartzell,et al.  Effect of arachidonic acid on the L‐type calcium current in frog cardiac myocytes. , 1996, The Journal of physiology.

[72]  R. Walsh,et al.  In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. , 1995, Circulation research.

[73]  D. Dietzen,et al.  Caveolin Is Palmitoylated on Multiple Cysteine Residues , 1995, The Journal of Biological Chemistry.

[74]  G. Dorn,et al.  Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. , 1994, The American journal of physiology.

[75]  R. Reneman,et al.  Fatty acid homeostasis in the normoxic and ischemic heart. , 1992, Physiological reviews.

[76]  T. Shimada,et al.  Modulation of voltage-dependent Ca channel current by arachidonic acid and other long-chain fatty acids in rabbit intestinal smooth muscle , 1992, The Journal of general physiology.

[77]  J. Ross,et al.  Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[78]  N. Dhalla,et al.  Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. , 1983, The American journal of physiology.

[79]  J. Oram,et al.  Regulation of fatty acid utilization in isolated perfused rat hearts. , 1973, The Journal of biological chemistry.

[80]  J. R. Evans Importance of Fatty Acid in Myocardial Metabolism , 1964, Circulation research.

[81]  R. Bing,et al.  Myocardial metabolism of fatty acids. , 1960, The Journal of clinical investigation.

[82]  L. Adorini,et al.  Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. , 2007, Methods in molecular biology.

[83]  J. Sadoshima,et al.  The cellular and molecular response of cardiac myocytes to mechanical stress. , 1997, Annual review of physiology.